Turkfleks %0.5 Metronidazole Infusion Solution
NDC Package 85160-100-10
Package Information
Turkfleks %0.5 Metronidazole Infusion Solution is medical and surgical infections caused by anaerobic bacteria sensitive to metronidazole in the treatment of infections, For prophylactic purposes in surgical procedures with a risk of anaerobic infection development, It is indicated in severe intestinal and hepatic amebiasis. Marketed by Turk Ilac Ve Serum Sanayi Anonim Sirketi, this product is identified by NDC 85160-100.
Identification & Billing
- RxCUI: 311683 - metroNIDAZOLE 500 MG in 100 ML Injection
- RxCUI: 311683 - 100 ML metronidazole 5 MG/ML Injection
- RxCUI: 311683 - metronidazole 500 MG per 100 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85160 - Turk Ilac Ve Serum Sanayi Anonim Sirketi
- 85160-100 - Turkfleks %0.5 Metronidazole Infusion Solution
- 85160-100-10 - 50 BAG in 1 BOX / 100 mL in 1 BAG (85160-100-01)
- 85160-100 - Turkfleks %0.5 Metronidazole Infusion Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85160-100-10 identifies a specific commercial package of 50 bag in 1 box / 100 ml in 1 bag (85160-100-01) of Turkfleks %0.5 Metronidazole Infusion Solution, labeled by Turk Ilac Ve Serum Sanayi Anonim Sirketi. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Turk Ilac Ve Serum Sanayi Anonim Sirketi on January 15, 2025. The current certification is valid through December 31, 2026.
How is this Turk Ilac Ve Serum Sanayi Anonim Sirketi product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85160010010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.